Skip to content
← Back to this collection

PUBLICATIONS · 35403816

Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2022 Aug
First author
Shima H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Shima H
      type
      Author
    2. name
      Kada A
      type
      Author
    3. name
      Tanizawa A
      type
      Author
    4. name
      Sato I
      type
      Author
    5. name
      Tono C
      type
      Author
    6. name
      Ito M
      type
      Author
    7. name
      Yuza Y
      type
      Author
    8. name
      Watanabe A
      type
      Author
    9. name
      Kamibeppu K
      type
      Author
    10. name
      Uryu H
      type
      Author
    11. name
      Koh K
      type
      Author
    12. name
      Imai C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Shima H
      type
      Author
    2. name
      Kada A
      type
      Author
    3. name
      Tanizawa A
      type
      Author
    4. name
      Sato I
      type
      Author
    5. name
      Tono C
      type
      Author
    6. name
      Ito M
      type
      Author
    7. name
      Yuza Y
      type
      Author
    8. name
      Watanabe A
      type
      Author
    9. name
      Kamibeppu K
      type
      Author
    10. name
      Uryu H
      type
      Author
    11. name
      Koh K
      type
      Author
    12. name
      Imai C
      type
      Author
    bibliography ids
    1. nci-bib-f3d57bbd23f2b6b9c3ac5369
    book metadata
    content sha256
    4d6288b7a40c52c845b486ba268733893ea58190a075edfce7a42bc8728644aa
    document type
    citation
    dois
    1. 10.1002/pbc.29699
    electronic publication date
    display
    2022 Apr 11
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35403816
    immutable id
    pubmed:35403816@4d6288b7a40c52c845b486ba268733893ea58190a075edfce7a42bc8728644aa
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    8
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29699
    volume
    69
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35403816
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      2b2dd5e5077ea4d03640c36ab58fd3dc6a91345f6c9c5cd1c21908ea10ad3fbc
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Aug
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35403816/
      title
      Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.

      Preserved source evidence · Not medical advice